Mbrace Therapeutics

Provider of a technology platform for the development of antibody-drug conjugate to treat cancer

placeSan Diego, California, United States calendar_todayFounded 2019 language mbracetrx.com

Innovation

6 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 41 times.

YearFilings
20232
20244
20255

Social engagement

Social engagement: 2.7K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include TPG.

Investor typeCountShare
Venture capital350%
Private equity233%
Bank & private debt117%

Hiring activity

Hires periodically

3 roles tracked across 3 of the last 12 months

19 Jan 2026 · Senior Director/Vice President, Finance · San Diego

6 Nov 2025 · Associate Director/Director, Clinical Science · San Diego

Based on job postings tracked across public sources.

Coming soon